Skip to main content
AGP Limited logo

AGP Limited - Investor Relations & Filings

Listed
Ticker · AGP ISIN · PK0113801010 PSX Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2023-09-13 Report Publication Anno…
Country PK Pakistan
Listing PSX AGP · 1 venue

About AGP Limited

https://agp.com.pk/

AGP Limited is a pharmaceutical company established in 1989. It specializes in the manufacturing, marketing, and distribution of a broad range of pharmaceutical and healthcare products. The company's portfolio includes internal medicine, gynaecology, pediatrics, orthopedic, cardiometabolic, and neuropsychiatry products. AGP Limited focuses on niche products, often manufactured and marketed under licensing arrangements with reputable European and American multinational pharmaceutical companies. The company operates with a strong commitment to quality, implementing an independent Quality Management System to ensure the safety, effectiveness, and high standards of its products for both domestic and export markets.

Recent filings

Filing Released Lang Actions
Corporate Breifing Session - June 2023
Report Publication Announcement Classification · 100% confidence The document is a formal notice from AGP Limited to the Pakistan Stock Exchange announcing a 'Corporate Briefing Session' (CBS) scheduled for September 20, 2023. It provides details on how investors and analysts can register to attend the session, which will cover financial results for the period ended June 30, 2023. Because the document is an invitation/announcement regarding an upcoming presentation rather than the presentation itself or a financial report, it falls under the 'Report Publication Announcement' category.
2023-09-13 English
Disclosure of Material Information - Resignation of Director
Regulatory Filings
2023-09-01 English
Transmission of Half Yearly Report for the period ended June 30, 2023
Regulatory Filings
2023-08-29 English
Emergent Board Meeting - August 31, 2023
Regulatory Filings Classification · 95% confidence The document is a formal notification from the Company Secretary to the Pakistan Stock Exchange regarding an upcoming board meeting. It explicitly states the meeting is for 'matters other than financial results' and announces a 'Closed Period' for share trading. Since it is a regulatory notification regarding corporate governance/administrative procedures and does not contain financial results or reports, it falls under the general regulatory filing category.
2023-08-29 English
Financial Results for the Half Year ended June 30, 2023
Earnings Release Classification · 95% confidence The document is an announcement of financial results for the half-year ended June 30, 2023, submitted to the Pakistan Stock Exchange. It contains the condensed interim statement of profit or loss and consolidated financial data. While it is addressed to the stock exchange, it provides the actual financial results (not just an announcement of a report's availability), fitting the definition of an Earnings Release (ER) for a half-year period. H1 2023
2023-08-25 English
Financial Results for the Half Year Ended June 30, 2023REVOKED
Interim / Quarterly Report Classification · 100% confidence The document contains the financial results for the half-year ended June 30, 2023, including detailed condensed interim statements of profit or loss for both the company and its consolidated group. While it begins with a cover letter to the Pakistan Stock Exchange, the inclusion of substantive financial statements (profit/loss tables) for the interim period qualifies it as an Interim/Quarterly Report rather than just an announcement. H1 2023
2023-08-25 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.